Endoplasmic Reticulum Stress in Cancer
MedComm · 2025-07 · 6 (7)
DOI: 10.1002/mco2.70263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 19.06.2025. Verfasst von Ruixin Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xiangya Hospital Central South University Changsha Hunan China. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Persistent and intense endoplasmic reticulum (ER) stress is widely acknowledged as a hallmark of tumorigenesis. To restore ER homeostasis, cells activate the unfolded protein response (UPR), which is aberrantly regulated in cancer cells. This review provides an in‐depth analysis of the mechanisms through which the UPR facilitates tumor progression. The UPR is activated by ER stress sensors such as inositol‐requiring enzyme 1 (IRE1α), protein kinase R‐like ER‐resident kinase (PERK), and activating transcription factor 6 (ATF6). These sensors regulate cancer cell proliferation, immune evasion, metastasis, and drug resistance. We summarize the crosstalk between the UPR and multiple signaling pathways, including mTOR, MAPK, and NF‐κB, which collectively promote tumor growth and metastasis. Additionally, we discuss the role of the UPR in modulating the tumor microenvironment to support angiogenesis and immune evasion. We also provide an overview of pharmacological agents targeting specific UPR pathways, such as GRP78 inhibitors, IRE1α inhibitors, PERK inhibitors, and ATF6 inhibitors, with the aim of developing more effective cancer therapies. This comprehensive review highlights the potential of targeting the UPR as a novel strategy for cancer treatment and underscores the need for further research to elucidate the complex interactions between the UPR and cancer progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Xiangya Hospital Central South University Changsha Hunan China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University Changsha Hunan Province China.
- Department of Breast Surgery, Xiangya Hospital Central South University Changsha Hunan China.
- Clinical Research Center for Breast Cancer in Hunan Province Changsha Hunan China.
- Molecular Bioengineering at Imperial College London London UK.
ORCID-Profile: Wenlong Wang
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhou, R., Wang, W., Li, B., Li, Z., Huang, J., & Li, X. (2025). Endoplasmic Reticulum Stress in Cancer. MedComm, 6(7). https://doi.org/10.1002/mco2.70263
Vancouver
Zhou R, Wang W, Li B, Li Z, Huang J, Li X. Endoplasmic Reticulum Stress in Cancer. MedComm. 2025;6(7). doi:10.1002/mco2.70263
BibTeX
@article{Zhou2025,
author = {Zhou, Ruixin and Wang, Wenlong and Li, Baizhao and Li, Zhu and Huang, Juan and Li, Xinying},
title = {Endoplasmic Reticulum Stress in Cancer},
journal = {MedComm},
year = {2025},
volume = {6},
number = {7},
doi = {10.1002/mco2.70263}
}
EUVIMED